Higher serum levels of IL-8 have been seen in advanced stages and progression of various cancer types that include colorectal, breast cancer, prostate, pancreatic, melanoma, ovarian and renal cancer [71]. This evidence concerns the gene CXCL8 and breast carcinoma.